Rhino-orbital-cerebral mucormycosis in times of COVID-19: A neurosurgical experience

Hershdeep Singh1, Sanjeev Dua1, Amitabh Goel1

  • 1Department of Neurosurgery, Max Hospital, Patparganj, New Delhi, India.

Abstract

Insights

Rhino-orbital-cerebral mucormycosis (ROCM) is a serious fungal infection seen in post-COVID-19 patients, especially those with diabetes mellitus. Early detection and management, including surgical intervention and strict blood sugar control, are crucial for better outcomes.

Area of Science:

  • Infectious Diseases
  • Neurosurgery
  • Endocrinology

Background:

  • The second wave of COVID-19 in India presented challenges, including a rise in mucormycosis cases.
  • Diabetes mellitus (DM) is a significant risk factor for mucormycosis.
  • This study focuses on rhino-orbital-cerebral mucormycosis (ROCM) during the COVID-19 second wave in North India.

Purpose of the Study:

  • To present the neurosurgical team's experience managing four cases of ROCM with cerebral involvement.
  • To highlight the challenges and outcomes of ROCM management in post-COVID-19 patients.

Main Methods:

  • A case series of four patients with ROCM and cerebral involvement managed by a neurosurgical team.
  • Surgical interventions included functional endoscopic sinus surgery (FESS), orbital decompression, and cranial surgery.

Main Results:

  • Three out of four patients had a history of COVID-19 pneumonia and corticosteroid treatment.
  • All patients had a history of diabetes mellitus.
  • Two patients underwent surgery; one patient expired before surgery could be attempted.

Conclusions:

  • Intensive follow-up is essential for early detection and management of ROCM in post-COVID-19 patients.
  • Surgical excision of fungal lesions is recommended, but radical excision of cerebral lesions may increase morbidity.
  • Strict blood sugar control in diabetic patients is paramount; steroids should be used cautiously, and antibiotics guided by culture and sensitivity.